Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models.
Platinum(II)-based anticancer drugs are associated with high reactivity and thus a poor biological stability. The platinum(IV)-complexes display potential advantages due to their greater stability and bioreductive activation, thereby allowing a greater proportion of the drug to arrive at the target intact. All compounds tested were able to produce cytotoxicity in monolayer cell cultures, however, the potencies of platinum(IV) drugs were lower than that observed for the platinum(II) compounds ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date: